Safety Toxicology Study of Reassortant Mopeia–Lassa Vaccine in Guinea Pigs
(1) Background: Mopeia–Lassa reassortant ML29 virus is an investigational, reassortant virus vaccine for the prevention of Lassa fever caused by Lassa virus (LASV). (2) Methods: The vaccine virus ML29-SF was prepared in Vero cells using a serum-free culture medium under Good Manufacturing Practice....
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2025-05-01
|
| Serie: | Future Pharmacology |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2673-9879/5/2/26 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|